Yamanouchi, Fujisawa become Astellas
Japanese drug companies Yamanouchi and Fujisawa have said that the entity to be created via their merger next year will be called Astellas Pharma, drawing on a Japanese word that means 'shine on tomorrow'.
Archives for May 24, 2004
Dowpharma reorganises biopharma ops
Dowpharma has unveiled plans to consolidate its biopharmaceutical custom process development activities to a single site in the US that it says will make it easier to respond to its clients' needs.
Mouse microarray from Applied Bio
Applied Biosystems has launched a mouse genome microarray that can be used to detect the expression of genes, even when they are expressed at very low levels.
SCOLR to go it alone after losing pharma partner
US drug delivery company SCOLR has been knocked back by the decision by one of its partners not to go ahead with a project based on its technology. But the company insists it will go it alone in tackling the pharmaceutical sector.
Small pharma to get SAP inroad
IBM has launched a new software package designed to make it easier for small and medium-sized pharmaceutical and biotecnology companies to cope with the compliance requirements of the US Food and Drug Administration.
Contract biopharma plant opens in Finland
In an unusual move, Finnish science park Medipolis has set up a new Good Manufacturing Practice (GMP) pilot plant to take advantage of the growing demand for biopharmaceutical production capacity.
SARS vaccine starts human trials
The outbreak of severe acute respiratory syndrome (SARS) earlier his month in China may have been contained, but it serves as a timely reminder of the need for continued efforts to develop drugs and vaccines for the virus, reports Phil Taylor.